Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
This is a trial for patients with newly diagnosed metastatic prostate cancer with 5 or fewer sites of metastases. The trial involves surgery (removal of the prostate), six months of hormone therapy, and stereotactic body radiotherapy to the sites of metastasis.
提供机构：
ClinicalTrials.gov
